Integer (NYSE:ITGR) Shares Gap Down to $123.27

Integer Holdings Co. (NYSE:ITGR) shares gapped down before the market opened on Thursday . The stock had previously closed at $123.27, but opened at $114.00. Integer shares last traded at $112.86, with a volume of 342,010 shares.

Analyst Ratings Changes

Several analysts recently weighed in on the company. Benchmark lifted their price objective on Integer from $105.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, March 28th. CL King began coverage on Integer in a report on Thursday, March 14th. They issued a “buy” rating and a $137.00 price target on the stock. Bank of America upgraded Integer from a “neutral” rating to a “buy” rating and lifted their target price for the company from $105.00 to $135.00 in a research note on Monday, April 15th. Finally, KeyCorp boosted their price objective on shares of Integer from $123.00 to $139.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 9th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $120.50.

Integer Stock Performance

The company has a quick ratio of 1.71, a current ratio of 2.80 and a debt-to-equity ratio of 0.64. The firm has a market cap of $3.72 billion, a PE ratio of 42.00, a P/E/G ratio of 1.63 and a beta of 1.10. The firm has a 50-day moving average price of $112.68 and a two-hundred day moving average price of $99.49.

Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, February 15th. The medical equipment provider reported $1.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.34 by $0.05. The company had revenue of $413.15 million during the quarter, compared to analysts’ expectations of $409.04 million. Integer had a return on equity of 10.80% and a net margin of 5.68%. The company’s revenue for the quarter was up 10.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.11 earnings per share. Research analysts forecast that Integer Holdings Co. will post 5.31 EPS for the current fiscal year.

Institutional Trading of Integer

Institutional investors have recently bought and sold shares of the business. Blue Trust Inc. raised its position in shares of Integer by 483.3% in the fourth quarter. Blue Trust Inc. now owns 455 shares of the medical equipment provider’s stock valued at $45,000 after purchasing an additional 377 shares during the period. Principal Securities Inc. purchased a new stake in shares of Integer during the 4th quarter worth approximately $67,000. Emerald Mutual Fund Advisers Trust raised its holdings in shares of Integer by 66.6% in the 3rd quarter. Emerald Mutual Fund Advisers Trust now owns 1,461 shares of the medical equipment provider’s stock worth $115,000 after purchasing an additional 584 shares during the period. Van ECK Associates Corp lifted its holdings in Integer by 22.0% during the third quarter. Van ECK Associates Corp now owns 1,733 shares of the medical equipment provider’s stock valued at $136,000 after purchasing an additional 313 shares during the last quarter. Finally, Quadrant Capital Group LLC lifted its stake in shares of Integer by 10.2% during the 4th quarter. Quadrant Capital Group LLC now owns 1,427 shares of the medical equipment provider’s stock valued at $141,000 after buying an additional 132 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.